We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

26 hedge funds and large institutions have $1.88M invested in Grace Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more capital invested

Capital invested by funds: $1.33M → $1.88M (+$554K)

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

8% more funds holding

Funds holding: 24 → 26 (+2)

0.01% more ownership

Funds ownership: 0.02% → 0.03% (+0.01%)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
2
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$886K
2
Citadel Advisors
Citadel Advisors
Florida
+$56.3K
3
Squarepoint
Squarepoint
New York
+$38.2K
4
Millennium Management
Millennium Management
New York
+$19K
5
UBS Group
UBS Group
Switzerland
+$13.3K

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$127K
2
Morgan Stanley
Morgan Stanley
New York
-$101K
3
VF
Virtu Financial
New York
-$92.1K
4
Jane Street
Jane Street
New York
-$60K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$31K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$979K +$886K +36,338 New
VF
2
Virtu Financial
New York
$411K -$92.1K -3,779 -20%
Morgan Stanley
3
Morgan Stanley
New York
$101K -$101K -4,161 -53%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$82K -$14.1K -579 -16%
Citadel Advisors
5
Citadel Advisors
Florida
$62K +$56.3K +2,310 New
EDRH
6
Edmond de Rothschild Holding
Switzerland
$56K – – –
Squarepoint
7
Squarepoint
New York
$53K +$38.2K +1,569 +392%
MMPW
8
Mitchell McLeod Pugh & Williams
Alabama
$25K – – –
SIAP
9
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$22K – – –
Millennium Management
10
Millennium Management
New York
$21K +$19K +780 New
PAG
11
Private Advisor Group
New Jersey
$17K – – –
UBS Group
12
UBS Group
Switzerland
$15K +$13.3K +544 New
LPL Financial
13
LPL Financial
California
$10K – – –
Commonwealth Equity Services
14
Commonwealth Equity Services
Massachusetts
$8K +$7.97K +327 New
N
15
Natixis
France
$7K +$6.41K +263 New
Bank of Montreal
16
Bank of Montreal
Ontario, Canada
$6K -$127K -5,208 -96%
FDCDDQ
17
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.1K – – –
Bank of America
18
Bank of America
North Carolina
$1K – – –
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$1K +$49 +2 +5%
ASN
20
Advisory Services Network
Georgia
$1K +$1.02K +42 New
RE
21
RBC Europe
United Kingdom
$17 – – –
Jane Street
22
Jane Street
New York
– -$60K -2,096 Closed
Two Sigma Advisers
23
Two Sigma Advisers
New York
– -$31K -1,067 Closed
TSS
24
Two Sigma Securities
New York
– -$29K -1,007 Closed
CCM
25
Campbell Capital Management
Florida
– -$18K -625 Closed
1
2

GRCE Hedge Fund Activity: Q2 2021 in Review

26 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2021, worth a combined $1.88M — up 42% from $1.33M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new GRCE positions and 6 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $886K. The largest seller was Bank of Montreal, cutting an estimated $127K.

  • 26 institutional investors held Grace Therapeutics (GRCE) as of Q2 2021, up from 24 in Q1 2021.
  • Funds reported $1.88M of Grace Therapeutics stock for Q2 2021, up 42% quarter-over-quarter.
  • 8 funds opened new Grace Therapeutics positions in Q2 2021 and 6 closed out, a net change of +2 holders.
  • The largest Grace Therapeutics buyer in Q2 2021 was Renaissance Technologies, an estimated $886K added.
  • The largest Grace Therapeutics seller in Q2 2021 was Bank of Montreal, an estimated $127K sold.

Based on aggregated 13F filings for Q2 2021.